在2024年ObesityWeek, 结构治疗法为肥胖症提供口服小分子治疗。 Structure Therapeutics presents oral small molecule treatments for obesity at ObesityWeek 2024.

结构治疗公司是一家生物制药公司,从11月3日至6日将在TX圣安东尼奥的Obesity Week 2024展示多张海报。 Structure Therapeutics, a biopharmaceutical firm, will present multiple posters at ObesityWeek 2024 in San Antonio, TX, from November 3-6. 重点包括新颖的口服小分子治疗肥胖症,如双亚米林和卡西托宁受体激动剂,以及深入了解小分子GLP-1受体激动剂GSBR-1290。 Highlights include novel oral small molecule treatments for obesity, such as dual amylin and calcitonin receptor agonists, and insights into GSBR-1290, a small molecule GLP-1 receptor agonist. 第一个介绍定于11月3日进行,第二个介绍的细节即将进行。 The first presentation is scheduled for November 3, while details for the second are forthcoming.